Stocklytics Platform
Asset logo for symbol ANIP
ANI Pharmaceuticals
ANIP82
$62.19arrow_drop_up1.36%$0.84
High Quality
Asset logo for symbol ANIP
ANIP82

$62.19

arrow_drop_up1.36%

Income Statement (ANIP)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
EBIT$15.05M$8.71M$15.35M$13.38M$9.89M
EBITDA$29.74M$23.90M$30.56M$28.07M$26.65M
gross Profit$73.58M$63.04M$83.72M$74.26M$69.07M
NET Income$18.20M$1.15M$9.94M$6.24M$1.43M
total Revenue$137.43M$131.65M$131.82M$116.54M$106.78M

Balance Sheet (ANIP)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt$81.71M$94.20M$92.80M$124.38M$218.55M
stockholders Equity$451.96M$432.74M$454.71M$434.47M$339.48M
total Assets$914.52M$904.42M$889.91M$859.34M$765.22M
total Debt$310.30M$315.32M$285.88M$286.09M$286.30M
total Liabilities$462.56M$471.67M$435.20M$424.86M$425.74M

Cash Flow (ANIP)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow-$19.72M-$11.91M$3.75M$80.15M-$4.54M
free Cash Flow$13.68M$39.96M$27.61M$13.80M$19.07M
investing Cash Flow----$6.82M-$2.35M
operating Cash Flow$18.26M$44.74M$32.16M$20.62M$21.42M

ANI Pharmaceuticals (ANIP) Financials

The income statement of ANI Pharmaceuticals Inc (ANIP) provides a comprehensive overview of the company's financial performance. It outlines the revenue generated, expenses incurred, and ultimately the net income earned by the company. ANIP's income statement reflects a strong financial performance, with consistently increasing gross profit and net income over the years. This demonstrates the company's ability to generate revenue and control costs effectively.

The earnings before interest and taxes (EBIT) of ANI Pharmaceuticals Inc (ANIP) is an important financial metric that measures the company's profitability before factoring in the impact of interest and taxes. ANIP has consistently reported positive EBIT figures, indicating a solid operational performance.

EBITDA, or earnings before interest, taxes, depreciation, and amortization, is another crucial financial measure that provides insight into a company's profitability. ANIP's EBITDA demonstrates a healthy financial position, highlighting the company's ability to generate cash flow from its operations.

The gross profit of ANI Pharmaceuticals Inc (ANIP) represents the revenue remaining after deducting the cost of goods sold. ANIP's gross profit has shown a consistent upward trend, signifying the company's efficient manufacturing and distribution processes.

Net income from stockholders refers to the portion of ANI Pharmaceuticals Inc (ANIP) earnings that is attributable to its stockholders. This metric indicates the company's profitability and is an important consideration for investors. ANIP has consistently reported positive net income from stockholders, indicating a strong financial performance.

Total revenue is a key financial metric that reflects the overall amount of income generated by ANI Pharmaceuticals Inc (ANIP) from its operations. ANIP's total revenue has exhibited steady growth, reflecting the success of its product portfolio and market presence.

The balance sheet of ANI Pharmaceuticals Inc (ANIP) provides a snapshot of the company's financial standing at a given point in time. It presents the company's assets, liabilities, and stockholders' equity. ANIP's balance sheet demonstrates a healthy financial position, with a strong asset base and minimal liabilities.

Cash equivalents represent highly liquid assets that can be readily converted into cash. ANI Pharmaceuticals Inc (ANIP) holds a significant amount of cash equivalents, which provides the company with the flexibility to meet its short-term financial obligations and pursue growth opportunities.

Net debt is a financial measure that represents a company's total debt minus its cash and cash equivalents. ANI Pharmaceuticals Inc (ANIP) has effectively managed its net debt, maintaining a favorable debt position. This indicates the company's ability to meet its financial obligations and reduce its reliance on external financing.

Stockholders' equity reflects the residual value of ANI Pharmaceuticals Inc (ANIP) assets after deducting its liabilities. ANIP's stockholders' equity has shown consistent growth, indicating a favorable financial position and the company's ability to generate profits.

Total assets represent the sum of all tangible and intangible assets owned by ANI Pharmaceuticals Inc (ANIP). ANIP's total assets have steadily increased, reflecting the company's growth and expansion.

Total debt refers to the outstanding obligations owed by ANI Pharmaceuticals Inc (ANIP) to creditors. ANIP has effectively managed its debt levels, maintaining a conservative debt position. This indicates the company's ability to meet its financial obligations and reduce its risk exposure.

Total liabilities represent the financial obligations owed by ANI Pharmaceuticals Inc (ANIP) to external parties. ANIP's total liabilities have been effectively managed, indicating a responsible approach to debt and a sustainable financial structure.

Cash flow is a critical financial metric that measures the movement of cash in and out of ANI Pharmaceuticals Inc (ANIP). ANIP has consistently generated positive cash flows from its operations, demonstrating the company's ability to generate cash and meet its financial obligations.

Financing cash flow refers to the cash inflows and outflows associated with ANI Pharmaceuticals Inc (ANIP) financing activities, such as issuing or repurchasing stock and taking on or repaying debt. ANIP's financing cash flow activities have been managed prudently, reflecting a balanced approach to funding the company's operations and growth initiatives.

Free cash flow is an important financial metric that measures the cash generated by ANI Pharmaceuticals Inc (ANIP) after deducting capital expenditures needed to maintain or expand its asset base. ANIP's free cash flow demonstrates a positive trend, indicating the company's ability to generate excess cash that can be used for strategic investments or returned to shareholders.

Investing cash flow reflects the cash inflows and outflows associated with ANI Pharmaceuticals Inc (ANIP) investing activities, such as acquiring or disposing of property, plant, and equipment, as well as investing in other companies. ANIP's investing cash flow activities have been managed effectively, supporting the company's growth and expansion objectives.

Operating cash flow is a key financial metric that measures the cash generated by ANI Pharmaceuticals Inc (ANIP) from its core business operations. ANIP has consistently reported positive operating cash flow, indicating a strong operational performance and the company's ability to generate cash from its day-to-day activities.

add ANI Pharmaceuticals  to watchlist

Keep an eye on ANI Pharmaceuticals

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level